ASO 作者反思：异质混合侵袭性乳管小叶乳腺癌的个体化治疗。
ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers.
发表日期：2023 Nov 12
作者：
Kush R Lohani, Tanya L Hoskin, Courtney N Day, Saba Yasir, Judy C Boughey, Amy C Degnim
来源：
ANNALS OF SURGICAL ONCOLOGY
摘要：
混合性浸润性导管小叶乳腺癌 (MIDLC) 是一种罕见的乳腺癌，具有不同的小叶和导管成分。由于癌症罕见且缺乏统一的诊断标准和报告，MIDLC 的特征、治疗和结果尚不清楚。需要更好地了解这种异质性乳腺癌并进行个体化管理。© 2023。外科肿瘤学会。
Mixed invasive ductolobular breast cancer (MIDLC) is a rare breast cancer with varying lobular and ductal components. Characteristics, management, and outcomes of MIDLC are not well understood due to the rarity of the cancer and the lack of uniform diagnostic criteria and reporting. There is a need for better understanding and individualized management of this heterogeneous spectrum of breast cancers.© 2023. Society of Surgical Oncology.